Cerevel Therapeutics Holdings, Inc. CERE
44.96 0.00 (+0.00%)
At closeJul 31, 2024, 4:00 PM EDT
44.96 Day range 44.99
52-week range unavailable
Analyst view
Consensus: hold
Hold
Price target (mean) 43.40 -3.5% downside
Now 44.96
- Target (low)
- 31.00
- Target (mean)
- 43.40
- Target (high)
- 45.00
Ratings (-1m) 9 0 buy · 9 hold · 0 sell
- Strong buy0
- Buy0
- Hold9
- Sell0
- Strong sell0
Recommendation trend
- 1 month ago 9
- 2 months ago 9
- 3 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.80 | -0.80 – -0.80 | -0.63 | -27.0% | 0 | 0.0% | 1 |
| Next quarter | -0.73 | -0.73 – -0.73 | -0.61 | -19.7% | 0 | 0.0% | 1 |
| Current year | -2.83 | -3.25 – -2.41 | -2.67 | -6.0% | 0 | 0.0% | 2 |
| Next year | -2.92 | -3.30 – -2.54 | -2.83 | -3.2% | 0 | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 27, 2023 | Piper Sandler | Initiated | — | Overweight |
| Aug 6, 2023 | Mizuho | Maintained | Neutral | Neutral |
| Aug 2, 2023 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 2, 2023 | B of A Securities | Downgrade | Buy | Neutral |
| Aug 2, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 22, 2023 | Goldman Sachs | Maintained | Neutral | Neutral |
| May 7, 2023 | Mizuho | Maintained | — | Neutral |
| May 3, 2023 | Wells Fargo | Upgrade | Equal-Weight | Overweight |
| Apr 9, 2023 | TD Cowen | Initiated | — | Outperform |
| Apr 2, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 16, 2023 | JP Morgan | Downgrade | Overweight | Neutral |
| Mar 8, 2023 | Mizuho | Maintained | — | Neutral |
| Feb 22, 2023 | Morgan Stanley | Maintained | — | Overweight |
| Feb 22, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Feb 22, 2023 | Wells Fargo | Downgrade | Overweight | Equal-Weight |
| Feb 21, 2023 | Goldman Sachs | Maintained | Neutral | Neutral |
| Dec 5, 2022 | JP Morgan | Maintained | — | Overweight |
| Nov 9, 2022 | Mizuho | Maintained | — | Neutral |
| Nov 8, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Oct 31, 2022 | Loop Capital | Initiated | — | Buy |
| Oct 19, 2022 | B of A Securities | Initiated | — | Buy |
| Sep 28, 2022 | Cantor Fitzgerald | Initiated | — | Overweight |
| Sep 25, 2022 | Wells Fargo | Initiated | — | Overweight |
| Sep 20, 2022 | Goldman Sachs | Maintained | — | Neutral |
| Sep 12, 2022 | Evercore ISI Group | Initiated | — | Outperform |
| Aug 22, 2022 | Mizuho | Maintained | — | Neutral |
| Aug 21, 2022 | Morgan Stanley | Maintained | — | Overweight |
| Aug 8, 2022 | Stifel | Maintained | — | Buy |
| Aug 2, 2022 | Mizuho | Maintained | — | Neutral |
| Jul 6, 2022 | Mizuho | Initiated | — | Neutral |